Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

August 19, 2016

Long-term Study of Flivas for BPH Identified Why Treatment Might Fail

News

A study exploring Flivas (naftopidil) in 117 patients with benign prostatic hyperplasia (BPH) demonstrates that long-term outcomes of the treatment vary widely. The report, “Three-year outcome analysis of alpha 1-blocker ... Read more

August 12, 2016August 12, 2016

LUTS Far More than Enlarged Prostate, Review Reveals

News

Lower urinary tract symptoms (LUTS) in men are not synonymous to the obstruction caused by prostate enlargement, two researchers from New Zealand wrote in a review. The report, “Recent advances ... Read more

August 5, 2016August 5, 2016

Widely Varying Estimates of BPH in South Korea Leads to Call for Better Study Approaches

News

An epidemiological study by researchers in South Korea shows that most aspects of lower urinary tract symptoms (LUTS) are as common there as in other previously examined populations. But the ... Read more

July 21, 2016July 21, 2016

LUTS in BPH Could Improve with Drugs that Target Bladder

News

While lower urinary tract symptoms (LUTS) in men are typically blamed on the enlargement of the prostate, a review from the University of Thessaly in Greece puts the spotlight on research showing ... Read more

July 14, 2016

Men Say Cialis Is Better Treatment for BPH and ED Rather Than Combination Therapy, Study Reports

News

Eli Lilly reports that treatment with its drug tadalafil (Cialis) — the only medicine approved for treating both benign prostatic hyperplasia (BPH) and erectile dysfunction — generates more treatment satisfaction than ... Read more

May 23, 2016May 23, 2016

BPH Acute Urinary Retention Treated Effectively with Silodosin and Dutasteride, Study Reports

News

Combining silodosin (known as Rapaflo in the U.S.) and dutasteride (Avodart) effectively and safely improves symptoms in patients with acute urinary retention caused by benign prostatic hyperplasia (BPH). While the ... Read more

May 20, 2016May 20, 2016

Garlic Shown to Prevent Prostate Growth as Effectively as a Drug in BPH Rat Model

News

Garlic taken for four weeks reduced prostate size and inflammatory markers in a testosterone-induced rat model of benign prostatic hyperplasia (BPH). The findings indicate that the herb might be a safe ... Read more

May 19, 2016May 19, 2016

Larger Prostates Found in Men with BPH and Metabolic Syndrome, Especially Asians

News

Prostate measurements in men with benign prostatic hyperplasia (BPH) are higher in those who also have metabolic syndrome, particularly in Asian men, a literature review and analysis concluded. Since symptom severity could not ... Read more

April 29, 2016April 29, 2016

UT Southwestern Urologist First in North Texas to Use Rezūm System, a Steam-Based Treatment for BPH

News

A University of Texas Southwestern Medical Center urologist is the first in North Texas to be certified for a new in-office method to shrink the prostate in men suffering from ... Read more

April 26, 2016April 26, 2016

Post-Surgery Drug for TURP Patients, Killox, Reported to Limit Inflammation and Aid Recovery

News

An open label study investigating the effects of Killox — an oral tablet formulation of curcumin, resveratrol, N-acetylcysteine, and zinc — in patients undergoing either transurethral resection of the prostate (TURP) or ... Read more